2025年3月24日 · Jump To TD-Specific Meds New Antipsychotics Brain Stimulation Outlook It can be scary when you or a loved one has been diagnosed with tardive dyskinesia (TD), a disorder …

2025年11月20日 · Explore the unique benefits of Ingrezza, a VMAT2 inhibitor for tardive dyskinesia, and how it compares to other treatment options.

2023年9月18日 · Discover cutting-edge treatments for tardive syndrome. Learn about FDA-approved meds, personalized approaches, and future perspectives in one place.

2025年7月14日 · Medications for Parkinsonism worsen tardive dyskinesia symptoms, and vice versa. Only 2 FDA-approved medications for tardive dyskinesia sit on the market—tetrabenazine and …

2025年3月20日 · The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, …

2025年11月7日 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to …

Tardive dyskinesia (TD) is a highly debilitating, chronic movement disorder that affects one in four people who take certain mental health treatments and is characterized by uncontrollable, abnormal, …

2025年5月13日 · Treatment Strategies for Tardive Dyskinesia A comprehensive approach is essential to ensure early detection and management of this potentially permanent movement disorder while …

2025年7月28日 · Key Takeaways Tardive dyskinesia results from chronic dopamine-receptor blockade, causing involuntary movements, primarily in the oral-buccal-lingual areas. VMAT2 inhibitors, including …

2025年4月25日 · Older adults face an elevated risk of developing tardive dyskinesia (TD) — a common side effect of antipsychotic medications. New results – appearing this week in The Journal of …